121 related articles for article (PubMed ID: 29932454)
1. Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark.
Pottegård A; Friis S; Verdoodt F; Dehlendorff C; Hallas J; Kjaer SK
Acta Obstet Gynecol Scand; 2018 Nov; 97(11):1332-1338. PubMed ID: 29932454
[TBL] [Abstract][Full Text] [Related]
2. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
3. Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study.
Guleria S; Jensen A; Toender A; Kjaer SK
Cancer Causes Control; 2020 Jan; 31(1):25-31. PubMed ID: 31673820
[TBL] [Abstract][Full Text] [Related]
4. Antihistamine use and risk of ovarian cancer: A population-based case-control study.
Verdoodt F; Pottegård A; Dehlendorff C; Jäättelä M; Hallas J; Friis S; Kjaer SK
Maturitas; 2019 Feb; 120():47-52. PubMed ID: 30583764
[TBL] [Abstract][Full Text] [Related]
5. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
6. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
7. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
9. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
[TBL] [Abstract][Full Text] [Related]
10. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
[TBL] [Abstract][Full Text] [Related]
12. Screening program in ovarian cancer: A logical step in clinical management? A meta-analysis.
Marchetti C; De Felice F; Perniola G; Lecce F; Vertechy L; Monti M; Musio D; Muzii L; Tombolini V; Benedetti Panici P
Curr Probl Cancer; 2018; 42(2):235-240. PubMed ID: 29433824
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy and ovarian cancer.
Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with epithelial ovarian cancer in women with endometriosis.
Huang CY; Cheng NM; Wang PH
Taiwan J Obstet Gynecol; 2020 May; 59(3):353-355. PubMed ID: 32416878
[No Abstract] [Full Text] [Related]
15. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1006-12. PubMed ID: 16167920
[TBL] [Abstract][Full Text] [Related]
16. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
[TBL] [Abstract][Full Text] [Related]
17. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
[TBL] [Abstract][Full Text] [Related]
18. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
[TBL] [Abstract][Full Text] [Related]
19. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
Guo N; Peng Z
J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]